IP Library Granted Patent US 7,123,957
Granted Patent B2
US 7,123,957 · App. 10/771,909 · Granted Oct 17, 2006

Transdermal drug delivery and analyte extraction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,123,957
App. No.
10/771,909
Granted
Oct 17, 2006
Kind
B2
Abstract

A device for ablating the stratum corneum epidermidis of a subject, including a plurality of electrodes, which are applied to the subject's skin at respective points. A power source applies electrical energy between two or more of the plurality of electrodes, in order to cause ablation of the stratum corneum primarily in an area intermediate the respective points.

Claims (30)

1. A device for ablating stratum corneum epidermidis of skin on the body of a subject, comprising:

a plurality of electrodes, which are adapted to be applied to the skin of the subject at respective points; and

a power source, which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance through the ablated area during a second time period, subsequent to the first time period,

wherein the power source is adapted to apply an iontophoretic current to drive the substance into the skin.

2. A device according to claim 1 , wherein the power source is adapted to apply the electrical energy by generating an electric field which causes an ablating current to flow through the stratum corneum, and wherein the device is adapted to reduce power dissipated in the stratum corneum responsive to variation of a characteristic of the ablating current.

3. A device according to claim 1 , wherein the power source is adapted to apply the electrical energy by generating an ablating alternating current, a frequency thereof being above about 100 Hz.

4. A device according to claim 3 , wherein the power source is adapted to generate the ablating alternating current such that the frequency is between about 1 kHz and about 300 kHz.

5. A device according to claim 1 , wherein the power source is adapted to apply the electrical energy between two of the electrodes at a voltage that is sufficient to cause electrical breakdown of the stratum corneum in less than 50 milliseconds.

6. A device according to claim 1 , wherein the power source is adapted to apply the iontophoretic current during a third time period, prior to the first time period.

7. A device according to claim 1 , wherein the power source is adapted to apply the iontophoretic current during a third time period, not prior to the first time period.

8. A device according to claim 1 , wherein the power source is adapted to apply the iontophoretic current prior to applying the electrical energy.

9. A device for ablating stratum corneum epidermidis of skin on the body of a subject, comprising:

a plurality of electrodes, which are adapted to be applied to the skin of the subject at respective points; and

a power source, which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance by diffusion through the ablated area during a second time period, subsequent to the first time period.

10. A device according to claim 9 , wherein the power source is adapted to generate an electric field which causes a current to flow through the stratum corneum, and wherein the device is adapted to reduce power dissipated in the stratum corneum responsive to variation of a characteristic of the current.

11. A device according to claim 9 , wherein the power source is adapted to generate alternating current, a frequency thereof being above about 100 Hz.

12. A device according to claim 11 , wherein the power source is adapted to generate the alternating current such that the frequency is between about 1 kHz and about 300 kHz.

13. A method for ablating stratum corneum epidermidis of a subject, comprising:

applying electrical energy between points on the skin, so as to cause ablation of an area of the stratum corneum during a first time period;

applying a drug to the ablated area during a second time period, subsequent to the first time period, so that passage of the drug through the stratum corneum is facilitated by the ablation; and

applying an iontophoretic current to drive the drug into the skin.

14. A method according to claim 13 , wherein applying the electrical energy comprises:

generating an electric field which causes an ablating current to flow through the stratum corneum; and

reducing power dissipated in the stratum corneum responsive to variation of a characteristic of the ablating current.

15. A method according to claim 13 , wherein applying the electrical energy comprises generating an ablating alternating current, a frequency thereof being above about 100 Hz.

16. A method according to claim 15 , wherein generating the ablating alternating current comprises generating the ablating alternating current such that the frequency is between about 1 kHz and about 300 kHz.

17. A method according to claim 13 , wherein applying the electrical energy comprises applying the electrical energy at a voltage that is sufficient to cause electrical breakdown of the stratum corneum in less than 50 milliseconds.

18. A method according to claim 13 , wherein applying the iontophoretic current comprises applying the iontophoretic current during a third time period, prior to the first time period.

19. A method according to claim 13 , wherein applying the iontophoretic current comprises applying the iontophoretic current during a third time period, not prior to the first time period.

20. A method according to claim 13 , wherein applying the iontophoretic current comprises applying the iontophoretic current prior to applying the electrical energy.

Assignments (6)
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2012
From: TRANSPHARMA MEDICAL LTD
To: SYNERON MEDICAL LTD
Reel/Frame 028256/0375 →
CHANGE OF NAME Recorded May 23, 2012
From: TRANSPHARMA LTD
To: TRANSPHARMA MEDICAL LTD
Reel/Frame 028256/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2012
From: AVRAHAMI, ZOHAR
To: ELECSYS LTD
Reel/Frame 028139/0515 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2012
From: ELECSYS LIMITED
To: TRANSPHARMA LTD
Reel/Frame 028146/0307 →